Content by Bio X Cell

Explore how immune cell populations are reshaped within the tumor microenvironment and how in vivo models can guide the development of next-generation combination immunotherapies.

Uncontrolled antibody variables, rather than experimental design, may be driving irreproducible science.

PD-L1 × TIGIT × LAG3 format enables simultaneous interrogation of three complementary checkpoint pathways within a single in vivo system

Peer-reviewed studies demonstrate consistent functional activity using the same antibodies across murine and human-relevant models.

Understanding tumor heterogeneity and immune evasion is vital for advancing cancer research.

High-quality functional antibodies are essential for organoid studies, helping reduce variability and improve translational reliability in preclinical research.

High-quality functional antibodies support reliable, consistent, and translatable outcomes across preclinical research models.

Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.

Scalable, reproducible, and customizable antibodies help scientists keep their research on track.   

Functional antibodies are key experimental tools for targeting the complex tumor microenvironment and developing new immunotherapies.

Researchers turn to preclinical models of metabolic, cardiovascular, and neurological diseases to determine how GLP-1 peptides move beyond diabetes treatment.

In this webinar, Noor Gammoh and Ravi Amaravadi will examine how autophagy influences cancer and its implications for new treatments.

Functional antibodies are highly versatile modulators of health and disease, making them vital tools for disease research and potential therapeutic agents.

Antibody isotypes vary in effector activity and distribution, shaping their roles in immunity and their applications in biomedical research.